Plan of record · information, not medical advice
What treats it now. What is coming. Whether you can get in. Every criterion quoted from the registry, and every trial we would tell you to avoid.
Paid for by the patient, so nobody has to be sold. We take no fee per enrolled patient and no payment to feature a trial.
01The page
Not a search box, not a result list. The whole field for one disease — approved options, recruiting trials, stopped trials and the criteria behind each one — laid out so a family can read it in one sitting.
Records are read from the registry API and stored verbatim — the page never paraphrases a criterion.
—
Recruiting
—
Stopped
—
Refused
Our reading
What the registered question means for a person with the disease.
“The record, quoted.”
Not enough published
02The problem
Everything you need is on the internet, scattered across registries, labels and press releases that were never written for a family deciding on Friday.
Regulator labels are written for prescribers. The registry is written for researchers. The news reports the press release. Nothing in the market says the one useful thing: this trial is a bad deal for you.
Reading the label is not reading the trial
Dozens of trials recruit for a single disease. A family will read four. The rest are not read — and the four are chosen by whoever searched last.
Attention is the scarcest resource here
Most terminated trials give an operational reason or none at all. The memory of a failure is free text, one trial at a time. Nowhere is it a mechanism's history.
Failures are the cheapest signal there is
The reading
Every recruiting trial, every stopped trial, every approved option — held as one readable page instead of a search result you have to run yourself.
See the landscapeTrial records read from the ClinicalTrials.gov API v2, stored verbatim. Coverage is stated on every page, not implied.
03The landscape
Each page is free in full: every approved option, every recruiting trial, every published criterion. No account, no paywall on the facts.
04What you buy
The free page is the whole field, quoted. The paid layer is one analysis per trial: what it tests, what it would take to succeed, and whether we would put a family into it.
A registry record states the question. We say what the registered outcome means for a person with the disease, in plain words.
What this class of drug has already failed at, trial by trial, with the sponsor's own stated reason for stopping.
When each answer is due, ordered — so a family knows what to wait for instead of reading every record.
A named trial we would tell you not to join, and why, in one sentence you can quote back to your clinician.
One trial, read in full
Our reading
What the registered question means for a person with the disease.
“The record, quoted.”
Not enough published to say
05How it works
Nothing about the flow asks you to trust us first. Read the whole landscape, then decide what a reading is worth.
Open the page for your condition. No account, no email, no sales call — the facts are free on purpose.
Every approved option with its effect size and what it does not do. Every recruiting trial with its criteria quoted, not paraphrased.
Pay for the analysis, or the brief on your own case. Every criterion comes back quoted, and the decision stays with you and your clinician.
06What it costs
The landscape is free on purpose — that is what makes the paid analysis credible. What you buy is the reading on top of it.
Free
$0forever
The whole landscape, in full. This is what makes the paid layer worth believing.
Membership
$69per year
The reading on top of the landscape, for one condition, for a year.
No fee per enrolled patient. No payment to feature a trial. No sponsored content anywhere on this site — including the free pages.
07Questions
Short answers, stated the same way we state them in the product.
One page with every trial for your disease, each criterion quoted back against your own numbers — and paid for by you, so nobody can buy a place on it.
